NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/05/2024
Back to search
Official data from USPTO
ONCOIMMUNIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONCOIMMUNIN
ST13
US500000076385441Class
1, 5
Filing
76385441
Registration
2870839
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/05/2024
Trademark type
Word
Nice classes
1, 5
Filing date
03/19/2002
Registration date
08/10/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
11/05/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1996-07-00
First use in commerce
1997-03-00
Drawing code
1
Owner type
03
Owner location
Gaithersburg, MD
Examiner
HUGHITT, ELIZABETH
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OncoImmunin, Inc.
Representatives
Valerie Brennan Plave Koch PLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
reagents for scientific or clinical medical research usenamely testing and study of disease and drug discovery
Class 5
medical diagnostic reagents for detection of disease
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
11/05/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/05/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/05/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/27/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/27/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/27/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/15/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/15/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/15/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/15/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/15/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/26/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/26/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/26/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/26/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
12/13/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
12/13/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/18/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/18/2010
E815
TEAS SECTION 8 & 15 RECEIVED
11/04/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
08/10/2004
PUBO
PUBLISHED FOR OPPOSITION
05/18/2004
NPUB
NOTICE OF PUBLICATION
04/28/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2004
FAXX
FAX RECEIVED
02/23/2004
CFIT
CASE FILE IN TICRS
10/11/2003
CNSL
LETTER OF SUSPENSION MAILED
08/13/2002
DOCK
ASSIGNED TO EXAMINER
07/18/2002
DOCK
ASSIGNED TO EXAMINER
07/15/2002
Continuous trademark protection
Get notified about every new filing that threatens ONCOIMMUNIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.